ES2024357A6 - Procedimiento de obtencion de halohidrato de 2-halometil-3,5-dimetil-4-metoxipiri-dina. - Google Patents

Procedimiento de obtencion de halohidrato de 2-halometil-3,5-dimetil-4-metoxipiri-dina.

Info

Publication number
ES2024357A6
ES2024357A6 ES9003113A ES9003113A ES2024357A6 ES 2024357 A6 ES2024357 A6 ES 2024357A6 ES 9003113 A ES9003113 A ES 9003113A ES 9003113 A ES9003113 A ES 9003113A ES 2024357 A6 ES2024357 A6 ES 2024357A6
Authority
ES
Spain
Prior art keywords
methoxypyridine
halomethyl
halohydrate
dimethyl
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES9003113A
Other languages
English (en)
Inventor
Coll Alberto Palomo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Quimica SA
Original Assignee
Centro Genesis para la Investigacion SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro Genesis para la Investigacion SL filed Critical Centro Genesis para la Investigacion SL
Priority to ES9003113A priority Critical patent/ES2024357A6/es
Priority to US07/796,070 priority patent/US5292886A/en
Publication of ES2024357A6 publication Critical patent/ES2024357A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/68One oxygen atom attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE HALOHIDRATO DE 2-HALOMETIL-3,5-DIMETIL-4-METOXIPIRIDINA, DE FORMULA FIGURA 1 (X Y X'' SON HALOGENOS, IGUALES O NO), QUE COMPRENDE UNA PRIMERA ETAPA DE 0-ACILACION Y SUBSIGUIENTE ACILOXILACION DEL GRUPO METILO EN POSICION 2 DEL N-OXIDO DE 2,3,5-TRIMETIL-4-METOXIPIRIDINA, OBTENIENDO UN COMPUESTO DE FORMULA FIGURA 2 (R ES METILO, TRICLOROMETILO O TRIFLUOROMETILO Y N ES 0 O 1) Y UNA ULTIMA ETPA DE HALOGENACION, EN LA QUE EL SUSTITUYENTE EN POSICION 2 DEVIENE HALOMETIL. EL COMPUESTO ES UN ANTECEDENTE DE SINTESIS DEL OMEPRAZOL, QUE ES UN MEDICAMENTO MUY EFICAZ PARA EL TRATAMIENTO DE ULCERAS GASTRICAS.
ES9003113A 1990-12-05 1990-12-05 Procedimiento de obtencion de halohidrato de 2-halometil-3,5-dimetil-4-metoxipiri-dina. Expired - Lifetime ES2024357A6 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES9003113A ES2024357A6 (es) 1990-12-05 1990-12-05 Procedimiento de obtencion de halohidrato de 2-halometil-3,5-dimetil-4-metoxipiri-dina.
US07/796,070 US5292886A (en) 1990-12-05 1991-11-20 Process for the preparation of 2-halomethyl-3,5-dimethyl-4-methoxypyridine halohydrate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9003113A ES2024357A6 (es) 1990-12-05 1990-12-05 Procedimiento de obtencion de halohidrato de 2-halometil-3,5-dimetil-4-metoxipiri-dina.

Publications (1)

Publication Number Publication Date
ES2024357A6 true ES2024357A6 (es) 1992-02-16

Family

ID=8269936

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9003113A Expired - Lifetime ES2024357A6 (es) 1990-12-05 1990-12-05 Procedimiento de obtencion de halohidrato de 2-halometil-3,5-dimetil-4-metoxipiri-dina.

Country Status (2)

Country Link
US (1) US5292886A (es)
ES (1) ES2024357A6 (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2066701A1 (es) * 1991-11-21 1995-03-01 Genesis Para La Investigacion Perfeccionamientos en el objeto de la patente 9102594 por procedimiento de obtencion de compuestos derivados de piridina.
WO2001079194A1 (es) * 2000-04-14 2001-10-25 Esteve Quimica, S.A. Procedimiento para la obtención de derivados de [[(piridil sustituido)metil]tio]bencimidazol

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103664750A (zh) * 2013-12-09 2014-03-26 惠州市莱佛士制药技术有限公司 一种拉唑氯代物的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0103353A3 (en) * 1982-09-13 1986-03-05 Genrad, Inc. Method of and apparatus for multiplexed automatic testing of electronic circuits and the like
SE8404065D0 (sv) * 1984-08-10 1984-08-10 Haessle Ab Novel biologically active compounds
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
AT391693B (de) * 1988-11-15 1990-11-12 Cl Pharma Verfahren zur herstellung von 3-5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2066701A1 (es) * 1991-11-21 1995-03-01 Genesis Para La Investigacion Perfeccionamientos en el objeto de la patente 9102594 por procedimiento de obtencion de compuestos derivados de piridina.
ES2067407A1 (es) * 1991-11-21 1995-03-16 Genesis Para La Investigacion Perfeccionamientos en el objeto de la patente 9102594 por procedimiento de obtencion de derivados de piridina.
WO2001079194A1 (es) * 2000-04-14 2001-10-25 Esteve Quimica, S.A. Procedimiento para la obtención de derivados de [[(piridil sustituido)metil]tio]bencimidazol
ES2171116A1 (es) * 2000-04-14 2002-08-16 Esteve Quimica Sa Procedimiento para la obtencion de derivados de (((piridil sustituido)metil)tio)bencimidazol.
US6723852B2 (en) * 2000-04-14 2004-04-20 Esteve Quimica, S.A. Method for obtaining derivatives of [[(pyridil substituted)methyl]thio]benzomidazol

Also Published As

Publication number Publication date
US5292886A (en) 1994-03-08

Similar Documents

Publication Publication Date Title
PL336580A1 (en) Fine-molecular compounds useful in treating inflammatory diseases
CS15691A3 (en) High-pressure coupling, method of high-pressure connexion manufacture and machine for high-pressure coupling assembly
CA2195690A1 (en) Method of making curved, shaped absorbent article
CS44091A3 (en) 1-phenylimidazole derivative, process of its preparation and use
DE69726714D1 (en) 9-oximsilyl erythromycin a derivate
AU6760987A (en) Method of treating alzheimer's disease
DE69112837D1 (de) Wasserlösliche pentacyclische triterpen-mischung sowie deren herstellung.
CA2013910A1 (en) Refractory assembly including inner and outer refractory members with interference shrink fit therebetween and method of formation thereof
HUT64864A (en) Liophylized preparative and method for manufacturing it
YU81685A (en) Process for preparation of derivatives of glycerophospholines and glycerophosphoethanolamines
HUT57724A (en) Process for producing dialkyl-(2,3-pyridinedicarboxylate) and its derivatives
AU7804787A (en) Method of preparing toxoid
HUT60318A (en) Compositions comprising isothiazolone derivative stabilized with phenoxyalkanol and process for producing and applying them
ES2024357A6 (es) Procedimiento de obtencion de halohidrato de 2-halometil-3,5-dimetil-4-metoxipiri-dina.
ZA925469B (en) Process for chiral thiazolidine-2,4-dione hypoglycemics and intermediates
PT79855A (en) Process for the preparation of indolphenantridines
DE3364253D1 (en) Novel azole dinucleotide compounds and methods for their production
FR2689876B1 (fr) Dispersions silico-acryliques, leur procédé d'obtention, leur application en stéréophotolithographie et procédé de préparation d'objets en résine.
AU8642991A (en) Yeast fiber composition and process for the production thereof
ES2124065T5 (es) Procedimiento continuo para la fabricacion de alcoxido sodico c4-c8.
EP0427083A3 (en) Horizontal metal-extrusion press
JPS5244357A (en) Manufacturing method for a plastic retainer for a sliding bearing
EP0327696A3 (en) High-tenacity water-soluble polyvinyl alcohol fiber and process for producing the same
HUT59681A (en) Process for producing new 15-nitro-2-beta,3-beta-dihadro- and 15-nitro-2-beta,3-beta,6,7-tetrahydro-tabersonine derivatives
AU7719491A (en) Therapeutic compound

Legal Events

Date Code Title Description
PC1A Transfer granted

Owner name: ESTEVE QUIMICA, S.A.

FD2A Announcement of lapse in spain

Effective date: 20110214